Skip to content

Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes

Regulation of Lipolysis by Insulin in Skeletal Muscle and Adipose Tissue in Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01680133
Enrollment
20
Registered
2012-09-07
Start date
2007-06-30
Completion date
2011-09-30
Last updated
2012-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

Inadequate suppression of intramuscular and adipose tissue lipolysis, and consequent excessive delivery of fatty acids to ectopic tissues (e.g. muscle, pancreas and liver) could play an important role in the development and exacerbating of insulin resistance. Therefore, the investigators propose to study the regulation of adipose tissue and skeletal muscle lipolysis, as well as further characterize the intracellular lipolytic pathways within these tissues, in obese normoglycaemic versus long-term diagnosed type 2 diabetic subjects.

Interventions

Sponsors

Netherlands Organisation for Scientific Research
CollaboratorOTHER_GOV
European Foundation for the Study of Diabetes
CollaboratorOTHER
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Caucasian * Normal blood pressure (SBP 100-140 mmHg, DBP 60-90 mmHg) * weight stable in last 3 months

Exclusion criteria

* Smokers * people with intensive fitness training (e.g. athletes \> 3 times/week) * History of cardiovascular diseases * Bleeding disorders * Use of medication interfering with the study endpoints/hypotheses (e.g. beta-blockers) * Not to be able to understand the study information * Subjects on a special diet or vegetarian * Blood donation 2 months prior to the study and during the study * Participating in an other study

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in insulin sensitivity of adipose tissue and skeletal muscle lipolysis8, 20 and 40 mU insulin (2 hours)Changes from baseline in glycerol (lactate, pyruvate and glucose) in tissue microdialysate during a 3 step euglycemic hyperinsulinemic clamp (8, 20 and 40mU of insulin), every step for 2h

Secondary

MeasureTime frameDescription
Baseline adipose tissue and skeletal muscle gene expressionbaselinegene expression of genes related to lipid, glucose metabolism, insulin signalling will be measured in baseline adipose tissue and skeletal muscle biopsies
Baseline skeletal muscle lipid accumulationBaselineBaseline skeletal muscle lipid accumulation is measured (TAG, DAG, Phospholipid and fatty acids)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026